Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 Debt-to-Equity is 0.09 as of Mar. 2026, which is 40% below its 10-year median of 0.15. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.52. The stock has 8 warning signs investors should review. Among 705 Medical Devices & Instruments companies, KMS Medisurgi ranks better than 70.21% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for KMS Medisurgi's Debt-to-Equity or its related term are showing as below:
BOM:540468'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07 Med: 0.15 Max: 0.77
Current: 0.09
During the past 13 years, the highest Debt-to-Equity Ratio of KMS Medisurgi was 0.77. The lowest was 0.07. And the median was 0.15.
BOM:540468's Debt-to-Equity is ranked better than 70.21% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs BOM:540468: 0.09
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
KMS Medisurgi Debt-to-Equity Related Terms
KMS Medisurgi Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a Debt-to-Equity of 0.09 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on KMS Medisurgi and its competitors. This is 40% below median its historical median of 0.15. Over the past decade, KMS Medisurgi's Debt-to-Equity has ranged from 0.07 to 0.77. According to the industry distribution chart, KMS Medisurgi ranks #210 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is KMS Medisurgi's Debt-to-Equity too high?
KMS Medisurgi's current Debt-to-Equity of 0.09 is 40% below median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.77. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. KMS Medisurgi's value of 0.09 is 60.9% below this industry median. Based on the distribution chart, KMS Medisurgi ranks #210 out of 705 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #210 out of 705 companies for Debt-to-Equity. This puts KMS Medisurgi in the upper half of its industry. The industry median Debt-to-Equity is 0.23. KMS Medisurgi's value of 0.09 is 60.9% below this benchmark. Historically, KMS Medisurgi's own Debt-to-Equity has ranged from 0.07 to 0.77 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 0.23, KMS Medisurgi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current Debt-to-Equity of 0.09 is 60.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current Debt-to-Equity is 0.09, which is 40% below median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current Debt-to-Equity of 0.09. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Debt-to-Equity is 0.09, which is 40% below median its 10-year median of 0.15 and 60.9% below the Medical Devices & Instruments industry median of 0.23. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Debt-to-Equity is 0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
Debt-to-Equity: 0.09 (40% below median its 10-year median of 0.15)
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 60.9% below the Medical Devices & Instruments median (#210 of 705)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
